BackAurisco Pharmaceutical ,Ltd. Overview

Aurisco Pharmaceutical ,Ltd. Receivables

Latest receivables for 605116.SS: $390M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$385.88M
↓ 3.60% YoYΔ $-14.41M vs prior year quarter

Peer trimmed avg / median

Loading

Aurisco Pharmaceutical ,Ltd. Receivables History

Loading

Aurisco Pharmaceutical ,Ltd. vs. peers: Receivables Comparison

Loading

Aurisco Pharmaceutical ,Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aurisco Pharmaceutical ,Ltd. (605116.SS) FAQ

As of the most recent data (September 2026), 605116.SS shows a receivables of $390M. That compares with $400M in the prior-year period — down 3.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 605116.SS's receivables is now $390M (was $400M) — a 3.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aurisco Pharmaceutical ,Ltd. is outperforming or lagging.

Tracking 605116.SS's receivables over time shows whether Aurisco Pharmaceutical ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $390M That compares with $400M in the prior-year period — down 3.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Aurisco Pharmaceutical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $390M) with ownership activity and broader fundamentals.

Questions & Answers